Recombinant human IL-1B is rapidly becoming a critical resource for scientists across several fields. This carefully manufactured version of interleukin-1 beta delivers advantages over endogenously present IL-1B, including improved quality and predictable effect. Investigators are leveraging it to better explore the function of IL-1B in complicated